BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2160668)

  • 1. [Differential diagnosis by MRT of cavernous hemangiomas and malignant tumors of the liver--advantages of the multi-echo technic].
    Koch M; Lüning M; Mühler A; Simon C
    Radiol Diagn (Berl); 1990; 31(2):127-34. PubMed ID: 2160668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic malignant tumour versus cavernous haemangioma: differentiation on multiple breath-hold turbo spin-echo MRI sequences with different T2-weighting and T2-relaxation time measurements on a single slice multi-echo sequence.
    Chan YL; Lee SF; Yu SC; Lai P; Ching AS
    Clin Radiol; 2002 Apr; 57(4):250-7. PubMed ID: 12014868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.
    Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM
    AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of hepatocellular carcinoma and hepatic metastasis from cysts and hemangiomas with calculated T2 relaxation times and the T1/T2 relaxation times ratio.
    Farraher SW; Jara H; Chang KJ; Ozonoff A; Soto JA
    J Magn Reson Imaging; 2006 Dec; 24(6):1333-41. PubMed ID: 17083093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cavernous hemangioma of the liver: assessment of MR tissue specificity with a simplified T2 index.
    Mirowitz SA; Lee JK; Heiken JP
    J Comput Assist Tomogr; 1990; 14(2):223-8. PubMed ID: 2312850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MRI imaging of liver neoplasma].
    Mio A; Suzuki T; Suzaki K
    Rinsho Hoshasen; 1989 Dec; 34(13):1579-84. PubMed ID: 2560082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: MR appearance mimicking cavernous hemangioma.
    Ohtomo K; Itai Y; Matuoka Y; Minami M; Okada Y; Kawauchi N; Iio M; Nagashima I; Shiga J
    J Comput Assist Tomogr; 1990; 14(4):650-2. PubMed ID: 2164541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T.
    Choi BI; Han MC; Kim CW
    Radiology; 1990 Jul; 176(1):103-6. PubMed ID: 2162066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal liver lesions: characterization with quantitative analysis of T2 relaxation time in TSE sequence with double echo time.
    Cittadini G; Santacroce E; Giasotto V; Rescinito G
    Radiol Med; 2004 Mar; 107(3):166-73. PubMed ID: 15031682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
    Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
    Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases.
    Quan XY; Sun XJ; Yu ZJ; Tang M
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):406-9. PubMed ID: 16109526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic tumors: quantitative tissue characterization with MR imaging.
    Egglin TK; Rummeny E; Stark DD; Wittenberg J; Saini S; Ferrucci JT
    Radiology; 1990 Jul; 176(1):107-10. PubMed ID: 2162067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging (MRI) in 100 cases of mass lesions in the liver.
    Meng T; Su XZ
    Chin Med J (Engl); 1990 Aug; 103(8):673-9. PubMed ID: 2173656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging.
    Ohtomo K; Itai Y; Furui S; Yashiro N; Yoshikawa K; Iio M
    Radiology; 1985 May; 155(2):421-3. PubMed ID: 2984719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between hemangiomas and metastases of the liver with ultrafast MR imaging: preliminary results with T2 calculations.
    Goldberg MA; Saini S; Hahn PF; Egglin TK; Mueller PR
    AJR Am J Roentgenol; 1991 Oct; 157(4):727-30. PubMed ID: 1892026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relaxation time measurements in the differential magnetic resonance tomographic diagnosis of liver tumors].
    Steudel A; Harder T; Träber F; Dewes W; Schlolaut KH; Köster O
    Rofo; 1989 Oct; 151(4):449-55. PubMed ID: 2554383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging.
    Li KC; Glazer GM; Quint LE; Francis IR; Aisen AM; Ensminger WD; Bookstein FL
    Radiology; 1988 Nov; 169(2):409-15. PubMed ID: 3174988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.